Man SM, Karki R, et al. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev 2017;277(1):61–75. DOI: 10.1111/imr.12534.
Miao EA, Rajan JV, et al. Caspase-1-induced pyroptotic cell death. Immunol Rev 2011;243(1):206–214. DOI: 10.1111/j.1600-065X.2011.01044.x.
Xia X, Wang X, et al. The role of pyroptosis in cancer: pro-cancer or pro-“host”? Cell Death Dis 2019;10(9):1–3. DOI: 10.1038/s41419-019-1883-8.
Wu CS, Chang KP, et al. ASC contributes to metastasis of oral cavity squamous cell carcinoma. Oncotarget 2016;7(31):50074–50085. DOI: 10.18632/oncotarget.10317.
Wei Q, Mu K, et al. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest 2014;94:52–62. DOI: 10.1038/labinvest.2013.126.
Yue E, Tuguzbaeva G, et al. Anthocyanin is involved in the activation of pyroptosis in oral squamous cell carcinoma. Phytomedicine 2019;56:286–294. DOI: 10.1016/j.phymed.2018.09.223.
Iriti M, Varoni EM. Chemopreventive Potential of Flavonoids in Oral Squamous Cell Carcinoma in Human Studies. Nutrients 2013;5(7):2564–2576. DOI: 10.3390/nu5072564.
Sarode G, Sarode SC, et al. Is oral squamous cell carcinoma unique in terms of intra-and inter-tumoral heterogeneity? Trans Res Oral Oncol 2017;2:11–16. DOI 10.1177/2057178X17703578.
Nilendu P, Sarode SC, et al. Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance. Cell Oncol (Dordr) 2018;41(4):353–367. DOI: 10.1007/s13402-018-0388-2.
Sarode SC, Sarode GS, et al. A new classification for potentially malignant disorders of the oral cavity. Oral Oncol 2011;47(9):920–921. DOI: 10.1016/j.oraloncology.2011.06.005.
Sarode SC, Sarode GS, et al. Oral potentially malignant disorders: precising the definition. Oral Oncol 2012;9(48):759–760. DOI: 10.1016/j.oraloncology.2012.02.025.
